Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

The Lancet Diabetes and Endocrinology, ‎2213-8587

Tidsskrift

  1. 2021
  2. Udgivet

    Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses

    Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration, Kårhus, L. L. & Linneberg, A., dec. 2021, I: The Lancet Diabetes and Endocrinology. 9, 12, s. 837-846 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. E-pub ahead of print

    Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals

    OPEN International Healthcare Professional Network and OPEN Legal Advisory Group, 12 nov. 2021, (E-pub ahead of print) I: The Lancet Diabetes and Endocrinology.

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. E-pub ahead of print

    Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    DAPA-CKD Trial Committees and Investigators, 4 okt. 2021, (E-pub ahead of print) I: The Lancet Diabetes and Endocrinology.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. E-pub ahead of print

    Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    DAPA-CKD Trial Committees and Investigators, 4 okt. 2021, (E-pub ahead of print) I: The Lancet Diabetes and Endocrinology.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  6. Udgivet

    Dulaglutide for erectile dysfunction in type 2 diabetes

    Madsbad, S., 1 aug. 2021, I: The Lancet Diabetes and Endocrinology. 9, 8, s. 472-473 2 s.

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  7. Udgivet
  8. Udgivet

    Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

    DAPA-CKD Trial Committees and Investigators, jan. 2021, I: The Lancet Diabetes and Endocrinology. 9, 1, s. 22-31 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  9. 2020
  10. Udgivet

    Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials

    Mann, J. F. E., Hansen, T., Idorn, T., Leiter, L. A., Marso, S. P., Rossing, P., Seufert, J., Tadayon, S. & Vilsbøll, T., 1 nov. 2020, I: The Lancet Diabetes and Endocrinology. 8, 11, s. 880-893 14 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  11. Udgivet

    Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

    CVD-REAL 2 Investigators and Study Group, 1 jul. 2020, I: The Lancet Diabetes and Endocrinology. 8, 7, s. 606-615 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  12. Udgivet

    Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis

    Derakhshan, A., Peeters, R. P., Taylor, P. N., Bliddal, S., Carty, D. M., Meems, M., Vaidya, B., Chen, L., Knight, B. A., Ghafoor, F., Popova, P. V., Mosso, L., Oken, E., Suvanto, E., Hisada, A., Yoshinaga, J., Brown, S. J., Bassols, J., Auvinen, J., Bramer, W. M., López-Bermejo, A., Dayan, C. M., French, R., Boucai, L., Vafeiadi, M., Grineva, E. N., Pop, V. J. M., Vrijkotte, T. G., Chatzi, L., Sunyer, J., Jiménez-Zabala, A., Riaño, I., Rebagliato, M., Lu, X., Pirzada, A., Männistö, T., Delles, C., Feldt-Rasmussen, U., Alexander, E. K., Nelson, S. M., Chaker, L., Pearce, E. N., Guxens, M., Steegers, E. A. P., Walsh, J. P. & Korevaar, T. I. M., jun. 2020, I: The Lancet Diabetes and Endocrinology. 8, 6, s. 501-510 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  13. Udgivet

    BPA and risk assessment

    Calafat, A. M., Koch, H. M., Andra, S. S., Antignac, J. P., Castaño, A., Choi, K., Covaci, A., Dekant, W., Doerge, D. R., Frederiksen, H., Göen, T., Kolossa-Gehring, M., Leblanc, A., Mueller, J. F., Nakayama, S. F., Nassif, J., St-Amand, A., Völkel, W., Wolff, M. S. & additional coauthors, 1 apr. 2020, I: The Lancet Diabetes and Endocrinology. 8, 4, s. 269-270 2 s.

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  14. Udgivet
  15. Udgivet
  16. Udgivet

    Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

    Hegele, R. A., Borén, J., Ginsberg, H. N., Arca, M., Averna, M., Binder, C. J., Calabresi, L., Chapman, M. J., Cuchel, M., von Eckardstein, A., Frikke-Schmidt, R., Gaudet, D., Hovingh, G. K., Kronenberg, F., Lütjohann, D., Parhofer, K. G., Raal, F. J., Ray, K. K., Remaley, A. T., Stock, J. K., Stroes, E. S., Tokgözoğlu, L. & Catapano, A. L., jan. 2020, I: The Lancet Diabetes and Endocrinology. 8, 1, s. 50-67 18 s.

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  17. 2019
  18. Udgivet
  19. Udgivet

    Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

    Kristensen, S. L., Rørth, R., Jhund, P. S., Docherty, K. F., Sattar, N., Preiss, D., Køber, L., Petrie, M. C. & McMurray, J. J. V., okt. 2019, I: The Lancet Diabetes and Endocrinology. 7, 10, s. 776-785 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  20. Udgivet

    Diabetes in pregnancy and epigenetic mechanisms-how the first 9 months from conception might affect the child's epigenome and later risk of disease

    Hjort, L., Novakovic, B., Grunnet, L. G., Maple-Brown, L., Damm, P., Desoye, G. & Saffery, R., okt. 2019, I: The Lancet Diabetes and Endocrinology. 7, 10, s. 796-806 11 s.

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  21. Udgivet

    The role of blood volume in cardiac dysfunction and reduced exercise tolerance in patients with diabetes

    Montero, D., Diaz-Canestro, C., Oberholzer, L. & Lundby, C., okt. 2019, I: The Lancet Diabetes and Endocrinology. 7, 10, s. 807-816 10 s.

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  22. Udgivet

    Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., Budaj, A. J., Diaz, R., Goodman, S. G., Hanotin, C., Harrington, R. A., Jukema, J. W., Loizeau, V., Lopes, R. D., Moryusef, A., Murin, J., Pordy, R., Ristic, A. D., Roe, M. T., Tuñón, J., White, H. D., Zeiher, A. M., Schwartz, G. G., Steg, P. G., Bang, L. E., ODYSSEY OUTCOMES committees and Investigators & Jeppesen, J. L., aug. 2019, I: The Lancet Diabetes and Endocrinology. 7, 8, s. 618-628 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  23. Udgivet

    Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

    PIONEER 5 Investigators, 1 jul. 2019, I: The Lancet Diabetes and Endocrinology. 7, 7, s. 515-527 13 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  24. Udgivet

    Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial

    Pollock, C., Stefánsson, B., Reyner, D., Rossing, P., Sjöström, C. D., Wheeler, D. C., Langkilde, A. M. & Heerspink, H. J. L., 1 jun. 2019, I: The Lancet Diabetes and Endocrinology. 7, 6, s. 429-441 13 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  25. Udgivet

    Analogue insulin as an essential medicine: the need for more evidence and lower prices

    Beran, D., Hemmingsen, B. & Yudkin, J. S., maj 2019, I: The Lancet Diabetes and Endocrinology. 7, 5, s. 338 1 s.

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  26. Udgivet

    Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    Heerspink, H. J. L., Greene, T., Tighiouart, H., Gansevoort, R. T., Coresh, J., Simon, A. L., Chan, T. M., Hou, F. F., Lewis, J. B., Locatelli, F., Praga, M., Schena, F. P., Levey, A. S., Inker, L. A., Chronic Kidney Disease Epidemiology Collaboration & Kamper, A-L., feb. 2019, I: The Lancet Diabetes and Endocrinology. 7, 2, s. 128-139 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  27. Udgivet

    Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management

    Pedersen-Bjergaard, U. & International Hypoglycaemia Study Group, 2019, I: The Lancet Diabetes and Endocrinology. 7, 5, s. 385-396 12 s.

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  28. 2018
  29. Udgivet

    Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial

    de Zeeuw, D., Renfurm, R. W., Bakris, G., Rossing, P., Perkovic, V., Hou, F. F., Nangaku, M., Sharma, K., Heerspink, H. J. L., Garcia-Hernandez, A. & Larsson, T. E., 1 dec. 2018, I: The Lancet Diabetes and Endocrinology. 6, 12, s. 925-933 8 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  30. Udgivet

    Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

    Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration, jul. 2018, I: The Lancet Diabetes and Endocrinology. 6, 7, s. 538-546 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  31. Udgivet

    Novel diabetes subgroups - Authors' reply

    Ahlqvist, E., Prasad, R. B., Tuomi, T., Rosengren, A. & Groop, L., jun. 2018, I: The Lancet Diabetes and Endocrinology. 6, 6, s. 440-441 2 s.

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  32. Udgivet

    LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial

    LeucoPatch II trial team, 2018, I: The Lancet Diabetes and Endocrinology. 6, 11, s. 870-878

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  33. 2017
  34. Udgivet

    Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis

    Birkeland, K. I., Jørgensen, M. E., Carstensen, B., Persson, F., Gulseth, H. L., Thuresson, M., Fenici, P., Nathanson, D., Nyström, T., Eriksson, J. W., Bodegård, J. & Norhammar, A., sep. 2017, I: The Lancet Diabetes and Endocrinology. 5, 9, s. 709-717 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  35. Udgivet

    Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

    Petrie, J. R., Chaturvedi, N., Ford, I., Brouwers, M. C. G. J., Greenlaw, N., Tillin, T., Hramiak, I., Hughes, A. D., Jenkins, A. J., Klein, B. E. K., Klein, R., Ooi, T. C., Rossing, P., Stehouwer, C. D. A., Sattar, N., Colhoun, H. M. & REMOVAL Study Group, aug. 2017, I: The Lancet Diabetes and Endocrinology. 5, 8, s. 597-609 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  36. Udgivet

    Glycaemic control and weight loss with semaglutide in type 2 diabetes

    Madsbad, S. & Holst, J. J., 1 maj 2017, I: The Lancet Diabetes and Endocrinology. 5, 5, s. 315-317

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  37. Udgivet

    Clinical relevance of the bile acid receptor TGR5 in metabolism

    van Nierop, F. S., Scheltema, M. J., Eggink, H. M., Pols, T. W., Sonne, D. P., Knop, F. K. & Soeters, M. R., mar. 2017, I: The Lancet Diabetes and Endocrinology. 5, 3, s. 224-233

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  38. Udgivet

    Objective assessment of dietary patterns by use of metabolic phenotyping: a randomised, controlled, crossover trial

    Garcia-Perez, I., Posma, J. M., Gibson, R., Chambers, E. S., Hansen, T. H., Vestergaard, H., Hansen, T., Beckmann, M., Pedersen, O., Elliott, P., Stamler, J., Nicholson, J. K., Draper, J., Mathers, J. C., Holmes, E. & Frost, G., mar. 2017, I: The Lancet Diabetes and Endocrinology. 5, 3, s. 184-195 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  39. Udgivet

    PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study

    Schmidt, A. F., Swerdlow, D. I., Holmes, M. V., Patel, R. S., Fairhurst-Hunter, Z., Lyall, D. M., Hartwig, F. P., Horta, B. L., Hyppönen, E., Power, C., Moldovan, M., van Iperen, E., Hovingh, G. K., Demuth, I., Norman, K., Steinhagen-Thiessen, E., Demuth, J., Bertram, L., Liu, T., Coassin, S., Willeit, J., Kiechl, S., Willeit, K., Mason, D., Wright, J., Morris, R., Wanamethee, G., Whincup, P., Ben-Shlomo, Y., McLachlan, S., Price, J. F., Kivimaki, M., Welch, C., Sanchez-Galvez, A., Marques-Vidal, P., Nicolaides, A., Panayiotou, A. G., Onland-Moret, N. C., van der Schouw, Y. T., Matullo, G., Fiorito, G., Guarrera, S., Sacerdote, C., Wareham, N. J., Langenberg, C., Scott, R., Luan, J., Husemoen, L. L. N., Linneberg, A., Simonsen, K. S. & LifeLines Cohort study group, feb. 2017, I: The Lancet Diabetes and Endocrinology. 5, 2, s. 97-105 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  40. Udgivet

    Key European guidelines for the diagnosis and management of patients with phenylketonuria

    van Spronsen, F. J., van Wegberg, A. M., Ahring, K., Bélanger-Quintana, A., Blau, N., Bosch, A. M., Burlina, A., Campistol, J., Feillet, F., Giżewska, M., Huijbregts, S. C., Kearney, S., Leuzzi, V., Maillot, F., Muntau, A. C., Trefz, F. K., van Rijn, M., Walter, J. H. & MacDonald, A., 9 jan. 2017, I: The Lancet Diabetes and Endocrinology. 5, 9, s. 743-56

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  41. 2016
  42. Udgivet

    Excessive gains in BMI during adolescence increase risks of cardiovascular mortality in men

    Baker, J. L., dec. 2016, I: The Lancet Diabetes and Endocrinology. 4, 12, s. 964-966 3 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  43. Udgivet

    Cardiac natriuretic peptides in plasma: from prediction to precision medicine

    Goetze, J. P. & Zois, N. E., okt. 2016, I: The Lancet Diabetes and Endocrinology. 4, 10, s. 803-5 3 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  44. Udgivet

    Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis

    Natriuretic Peptides Studies Collaboration, Willeit, P., Kaptoge, S., Welsh, P., Butterworth, A., Chowdhury, R., Spackman, S., Pennells, L., Gao, P., Burgess, S., Freitag, D., Sweeting, M., Wood, A., Cook, N., Judd, S., Trompet, S., Nambi, V., Olsen, M., Everett, B., Kee, F., Ärnlöv, J., Salomaa, V., Levy, D., Kauhanen, J., Laukkanen, J., Kavousi, M., Ninomiya, T., Casas, J-P., Daniels, L., Lind, L., Kistorp, C., Rosenberg, J., Mueller, T., Rubattu, S., Panagiotakos, D., Franco, O., de Lemos, J., Luchner, A., Kizer, J., Kiechl, S., Salonen, J., Goya Wannamethee, S., de Boer, R., Nordestgaard, B., Andersson, J., Jørgensen, T., Melander, O., Ballantyne, C., DeFilippi, C., Ridker, P., Cushman, M., Rosamond, W., Thompson, S., Gudnason, V., Sattar, N., Danesh, J. & Di Angelantonio, E., okt. 2016, I: The Lancet Diabetes and Endocrinology. 4, 10, s. 840-9 10 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  45. Udgivet

    Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus

    Frandsen, C. S., Dejgaard, T. F. & Madsbad, S., okt. 2016, I: The Lancet, Diabetes & Endocrinology. 4, 9, s. 766-780

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  46. Udgivet

    Lipoprotein(a) and familial hypercholesterolaemia - Authors' reply

    Langsted, A., Kamstrup, P. R., Benn, M., Tybjærg-Hansen, A. & Nordestgaard, B. G., sep. 2016, I: The Lancet Diabetes and Endocrinology. 4, 9, s. 730-1 2 s.

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  47. Udgivet
  48. Udgivet

    Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial

    Heerspink, H. J. L., Persson, F., Brenner, B. M., Chaturvedi, N., Brunel, P., McMurray, J. J., Desai, A. S., Solomon, S. D., Pfeffer, M. A., Parving, H-H. & de Zeeuw, D., apr. 2016, I: The Lancet Diabetes and Endocrinology. 4, 4, s. 309-17 9 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  49. Udgivet
  50. 2015
  51. Udgivet

    Smoking and diabetes risk: building a causal case with clinical implications

    Sattar, N., Sorensen, T., Taylor, A. E., Morris, R. & Munafò, M. R., dec. 2015, I: The Lancet, Diabetes & Endocrinology. 3, 12, s. 918-20 3 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  52. Udgivet

    Testosterone in women-the clinical significance

    Davis, S. R. & Jacobsen, S. W., dec. 2015, I: The Lancet, Diabetes & Endocrinology. 3, 12, s. 980-92 13 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  53. Udgivet

    Effects of RAS inhibitors on diabetic retinopathy

    Parving, H-H. & Persson, F., maj 2015, I: The Lancet, Diabetes & Endocrinology. 3, 5, s. 315-316 2 s.

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  54. Udgivet

    Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis

    Interleukin 1 Genetics Consortium (Anne Tybjærg-Hansen, Børge G. Nordestgaard, members), apr. 2015, I: The Lancet, Diabetes & Endocrinology. 3, 4, s. 243-53 11 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  55. Udgivet

    Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial

    de Zeeuw, D., Anzalone, D. A., Cain, V. A., Cressman, M. D., Heerspink, H. J. L., Molitoris, B. A., Monyak, J. T., Parving, H-H., Remuzzi, G., Sowers, J. R. & Vidt, D. G., 3 feb. 2015, I: The Lancet, Diabetes & Endocrinology. 3, 3, s. 181-190

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  56. Udgivet
  57. Udgivet

    Long working hours, socioeconomic status, and the risk of incident type 2 diabetes: a meta-analysis of published and unpublished data from 222 120 individuals

    Kivimäki, M., Virtanen, M., Kawachi, I., Nyberg, S. T., Alfredsson, L., Batty, G. D., Bjorner, J. B., Borritz, M., Brunner, E. J., Burr, H., Dragano, N., Ferrie, J. E., Fransson, E. I., Hamer, M., Heikkilä, K., Knutsson, A., Koskenvuo, M., Madsen, I. E. H., Nielsen, M. L., Nordin, M., Oksanen, T., Pejtersen, J. H., Pentti, J., Rugulies, R., Salo, P., Siegrist, J., Steptoe, A., Suominen, S., Theorell, T., Vahtera, J., Westerholm, P. J. M., Westerlund, H., Singh-Manoux, A. & Jokela, M., jan. 2015, I: The Lancet, Diabetes & Endocrinology. 3, 1, s. 27-34 8 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Forrige 1 2 Næste

ID: 42145379